The World Market for Ambergris, Castoreum, Civet, Musk, Cantharides, Bile, Glands, and Other Animal Products Used in Pharmaceutical Products: A 2024 Global Trade Perspective
This report was created for strategic planners, international executives, and import/export managers who are concerned with the market for ambergris, castoreum, civit, musk, cantharides, bile, glands, and other animal products used in the preparation of pharmaceutical products. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. Professor Philip M. Parker, the Chair Professor of Management Science at INSEAD, has developed a methodology, based on macroeconomic and trade models, to estimate the market for ambergris, castoreum, civit, musk, cantharides, bile, glands, and other animal products used in the preparation of pharmaceutical products for those countries serving the world market via exports or supplying from various countries via imports. He does so for the current year based on a variety of key historical indicators and econometric models.
'Ambergris, castoreum, civit, musk, cantharides, bile, glands, and other animal products used in the preparation of pharmaceutical products' as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defines 'ambergris, castoreum, civit, musk, cantharides, bile, glands, and other animal products used in the preparation of pharmaceutical products' is 29198.
'Ambergris, castoreum, civit, musk, cantharides, bile, glands, and other animal products used in the preparation of pharmaceutical products' as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defines 'ambergris, castoreum, civit, musk, cantharides, bile, glands, and other animal products used in the preparation of pharmaceutical products' is 29198.
1 METHODOLOGY
1.1 OUR APPROACH
2 THE WORLD MARKET
2.1 EXPORTS
2.1.1 THE WORLD MARKET: AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS EXPORT SUPPLIES IN 2024
2.2 IMPORTS
2.2.1 THE WORLD MARKET: IMPORTED AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS IN 2024
3 EXPORTS
3.1 AFRICA: EXPORT SUPPLIES OF AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS IN 2024
3.1.1 EXECUTIVE SUMMARY
3.1.2 ANGOLA
3.1.3 ETHIOPIA
3.1.4 KENYA
3.1.5 MALI
3.1.6 MOROCCO
3.1.7 NAMIBIA
3.1.8 NIGERIA
3.1.9 SOUTH AFRICA
3.1.10 TANZANIA
3.1.11 UGANDA
3.2 ASIA: EXPORT SUPPLIES OF AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS IN 2024
3.2.1 EXECUTIVE SUMMARY
3.2.2 CHINA
3.2.3 HONG KONG
3.2.4 INDIA
3.2.5 INDONESIA
3.2.6 JAPAN
3.2.7 MALAYSIA
3.2.8 SINGAPORE
3.2.9 SOUTH KOREA
3.2.10 SRI LANKA
3.2.11 THAILAND
3.2.12 THE PHILIPPINES
3.3 EUROPE: EXPORT SUPPLIES OF AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS IN 2024
3.3.1 EXECUTIVE SUMMARY
3.3.2 AUSTRIA
3.3.3 BELARUS
3.3.4 BELGIUM
3.3.5 BULGARIA
3.3.6 DENMARK
3.3.7 FINLAND
3.3.8 FRANCE
3.3.9 GERMANY
3.3.10 HUNGARY
3.3.11 IRELAND
3.3.12 ITALY
3.3.13 KAZAKHSTAN
3.3.14 POLAND
3.3.15 PORTUGAL
3.3.16 ROMANIA
3.3.17 RUSSIA
3.3.18 SPAIN
3.3.19 SWEDEN
3.3.20 SWITZERLAND
3.3.21 THE NETHERLANDS
3.3.22 THE UNITED KINGDOM
3.4 LATIN AMERICA: EXPORT SUPPLIES OF AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS IN 2024
3.4.1 EXECUTIVE SUMMARY
3.4.2 ARGENTINA
3.4.3 BOLIVIA
3.4.4 BRAZIL
3.4.5 CHILE
3.4.6 COLOMBIA
3.4.7 COSTA RICA
3.4.8 ECUADOR
3.4.9 EL SALVADOR
3.4.10 GUATEMALA
3.4.11 HONDURAS
3.4.12 MEXICO
3.4.13 NICARAGUA
3.4.14 PANAMA
3.4.15 PARAGUAY
3.4.16 PERU
3.4.17 URUGUAY
3.4.18 VENEZUELA
3.5 NORTH AMERICA & THE CARIBBEAN: EXPORT SUPPLIES OF AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS IN 2024
3.5.1 EXECUTIVE SUMMARY
3.5.2 CANADA
3.5.3 THE BAHAMAS
3.5.4 THE DOMINICAN REPUBLIC
3.5.5 THE UNITED STATES
3.6 OCEANIA: EXPORT SUPPLIES OF AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS IN 2024
3.6.1 EXECUTIVE SUMMARY
3.6.2 AUSTRALIA
3.6.3 NEW ZEALAND
3.7 THE MIDDLE EAST: EXPORT SUPPLIES OF AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS IN 2024
3.7.1 EXECUTIVE SUMMARY
3.7.2 KYRGYZSTAN
3.7.3 LEBANON
3.7.4 PAKISTAN
3.7.5 UZBEKISTAN
4 IMPORTS
4.1 AFRICA: AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS IMPORTS IN 2024
4.1.1 EXECUTIVE SUMMARY
4.1.2 NAMIBIA
4.1.3 SOUTH AFRICA
4.2 ASIA: AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS IMPORTS IN 2024
4.2.1 EXECUTIVE SUMMARY
4.2.2 CHINA
4.2.3 HONG KONG
4.2.4 INDIA
4.2.5 JAPAN
4.2.6 MACAU
4.2.7 MALAYSIA
4.2.8 SINGAPORE
4.2.9 SOUTH KOREA
4.2.10 TAIWAN
4.2.11 THAILAND
4.3 EUROPE: AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS IMPORTS IN 2024
4.3.1 EXECUTIVE SUMMARY
4.3.2 AUSTRIA
4.3.3 BELARUS
4.3.4 DENMARK
4.3.5 FRANCE
4.3.6 GERMANY
4.3.7 HUNGARY
4.3.8 ITALY
4.3.9 LITHUANIA
4.3.10 POLAND
4.3.11 ROMANIA
4.3.12 RUSSIA
4.3.13 SPAIN
4.3.14 SWITZERLAND
4.3.15 THE NETHERLANDS
4.3.16 THE UNITED KINGDOM
4.3.17 UKRAINE
4.4 LATIN AMERICA: AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS IMPORTS IN 2024
4.4.1 EXECUTIVE SUMMARY
4.4.2 ARGENTINA
4.4.3 BRAZIL
4.4.4 MEXICO
4.5 NORTH AMERICA & THE CARIBBEAN: AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS IMPORTS IN 2024
4.5.1 EXECUTIVE SUMMARY
4.5.2 CANADA
4.5.3 THE UNITED STATES
4.6 OCEANIA: AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS IMPORTS IN 2024
4.6.1 EXECUTIVE SUMMARY
4.6.2 AUSTRALIA
4.6.3 NEW ZEALAND
5 DISCLAIMERS, WARRANTIES, AND USER AGREEMENT PROVISIONS
5.1 DISCLAIMERS & SAFE HARBOR
5.2 ICON GROUP INTERNATIONAL, INC. USER AGREEMENT PROVISIONS
1.1 OUR APPROACH
2 THE WORLD MARKET
2.1 EXPORTS
2.1.1 THE WORLD MARKET: AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS EXPORT SUPPLIES IN 2024
2.2 IMPORTS
2.2.1 THE WORLD MARKET: IMPORTED AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS IN 2024
3 EXPORTS
3.1 AFRICA: EXPORT SUPPLIES OF AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS IN 2024
3.1.1 EXECUTIVE SUMMARY
3.1.2 ANGOLA
3.1.3 ETHIOPIA
3.1.4 KENYA
3.1.5 MALI
3.1.6 MOROCCO
3.1.7 NAMIBIA
3.1.8 NIGERIA
3.1.9 SOUTH AFRICA
3.1.10 TANZANIA
3.1.11 UGANDA
3.2 ASIA: EXPORT SUPPLIES OF AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS IN 2024
3.2.1 EXECUTIVE SUMMARY
3.2.2 CHINA
3.2.3 HONG KONG
3.2.4 INDIA
3.2.5 INDONESIA
3.2.6 JAPAN
3.2.7 MALAYSIA
3.2.8 SINGAPORE
3.2.9 SOUTH KOREA
3.2.10 SRI LANKA
3.2.11 THAILAND
3.2.12 THE PHILIPPINES
3.3 EUROPE: EXPORT SUPPLIES OF AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS IN 2024
3.3.1 EXECUTIVE SUMMARY
3.3.2 AUSTRIA
3.3.3 BELARUS
3.3.4 BELGIUM
3.3.5 BULGARIA
3.3.6 DENMARK
3.3.7 FINLAND
3.3.8 FRANCE
3.3.9 GERMANY
3.3.10 HUNGARY
3.3.11 IRELAND
3.3.12 ITALY
3.3.13 KAZAKHSTAN
3.3.14 POLAND
3.3.15 PORTUGAL
3.3.16 ROMANIA
3.3.17 RUSSIA
3.3.18 SPAIN
3.3.19 SWEDEN
3.3.20 SWITZERLAND
3.3.21 THE NETHERLANDS
3.3.22 THE UNITED KINGDOM
3.4 LATIN AMERICA: EXPORT SUPPLIES OF AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS IN 2024
3.4.1 EXECUTIVE SUMMARY
3.4.2 ARGENTINA
3.4.3 BOLIVIA
3.4.4 BRAZIL
3.4.5 CHILE
3.4.6 COLOMBIA
3.4.7 COSTA RICA
3.4.8 ECUADOR
3.4.9 EL SALVADOR
3.4.10 GUATEMALA
3.4.11 HONDURAS
3.4.12 MEXICO
3.4.13 NICARAGUA
3.4.14 PANAMA
3.4.15 PARAGUAY
3.4.16 PERU
3.4.17 URUGUAY
3.4.18 VENEZUELA
3.5 NORTH AMERICA & THE CARIBBEAN: EXPORT SUPPLIES OF AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS IN 2024
3.5.1 EXECUTIVE SUMMARY
3.5.2 CANADA
3.5.3 THE BAHAMAS
3.5.4 THE DOMINICAN REPUBLIC
3.5.5 THE UNITED STATES
3.6 OCEANIA: EXPORT SUPPLIES OF AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS IN 2024
3.6.1 EXECUTIVE SUMMARY
3.6.2 AUSTRALIA
3.6.3 NEW ZEALAND
3.7 THE MIDDLE EAST: EXPORT SUPPLIES OF AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS IN 2024
3.7.1 EXECUTIVE SUMMARY
3.7.2 KYRGYZSTAN
3.7.3 LEBANON
3.7.4 PAKISTAN
3.7.5 UZBEKISTAN
4 IMPORTS
4.1 AFRICA: AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS IMPORTS IN 2024
4.1.1 EXECUTIVE SUMMARY
4.1.2 NAMIBIA
4.1.3 SOUTH AFRICA
4.2 ASIA: AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS IMPORTS IN 2024
4.2.1 EXECUTIVE SUMMARY
4.2.2 CHINA
4.2.3 HONG KONG
4.2.4 INDIA
4.2.5 JAPAN
4.2.6 MACAU
4.2.7 MALAYSIA
4.2.8 SINGAPORE
4.2.9 SOUTH KOREA
4.2.10 TAIWAN
4.2.11 THAILAND
4.3 EUROPE: AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS IMPORTS IN 2024
4.3.1 EXECUTIVE SUMMARY
4.3.2 AUSTRIA
4.3.3 BELARUS
4.3.4 DENMARK
4.3.5 FRANCE
4.3.6 GERMANY
4.3.7 HUNGARY
4.3.8 ITALY
4.3.9 LITHUANIA
4.3.10 POLAND
4.3.11 ROMANIA
4.3.12 RUSSIA
4.3.13 SPAIN
4.3.14 SWITZERLAND
4.3.15 THE NETHERLANDS
4.3.16 THE UNITED KINGDOM
4.3.17 UKRAINE
4.4 LATIN AMERICA: AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS IMPORTS IN 2024
4.4.1 EXECUTIVE SUMMARY
4.4.2 ARGENTINA
4.4.3 BRAZIL
4.4.4 MEXICO
4.5 NORTH AMERICA & THE CARIBBEAN: AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS IMPORTS IN 2024
4.5.1 EXECUTIVE SUMMARY
4.5.2 CANADA
4.5.3 THE UNITED STATES
4.6 OCEANIA: AMBERGRIS, CASTOREUM, CIVIT, MUSK, CANTHARIDES, BILE, GLANDS, AND OTHER ANIMAL PRODUCTS USED IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS IMPORTS IN 2024
4.6.1 EXECUTIVE SUMMARY
4.6.2 AUSTRALIA
4.6.3 NEW ZEALAND
5 DISCLAIMERS, WARRANTIES, AND USER AGREEMENT PROVISIONS
5.1 DISCLAIMERS & SAFE HARBOR
5.2 ICON GROUP INTERNATIONAL, INC. USER AGREEMENT PROVISIONS
